Cargando…
The stability of outcomes of cancellous autografts with acellular membrane for extended osteochondritis of the knee. Outcomes for 22 AMIC® grafts at an average follow-up of 4 years
OBJECTIVES: Loss of osteochondral substances resulting from osteochondritis dissecans (OCD) of the knee are arthrogenic in the long term. When they exceed 2 cm(2), the Autologous Matrix Induced Chondrogenesis (AMIC®) technique is one of the methods used in France. The objective of this study was to...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917857/ http://dx.doi.org/10.1177/2325967121S00020 |
_version_ | 1783657794086371328 |
---|---|
author | Pauvert, Adrien Chainard, Caroline Vincelot Buisson, Xavier Robert, Henri |
author_facet | Pauvert, Adrien Chainard, Caroline Vincelot Buisson, Xavier Robert, Henri |
author_sort | Pauvert, Adrien |
collection | PubMed |
description | OBJECTIVES: Loss of osteochondral substances resulting from osteochondritis dissecans (OCD) of the knee are arthrogenic in the long term. When they exceed 2 cm(2), the Autologous Matrix Induced Chondrogenesis (AMIC®) technique is one of the methods used in France. The objective of this study was to evaluate the medium-term results of the AMIC® technique. METHODS: This was a consecutive, prospective, single-center, single-operator series of 22 patients (13 men, 9 women, mean age 28 years (15-51)) treated by AMIC® (spongy bone graft + sutured collagen membrane) between September 2011 and November 2016. Previous surgery had been performed on 17 patients. According to the ICRS classification, the lesion was stage IV in 21 cases and stage III in 1 case. The sites were: condylar: 19 cases, patellar: 2 cases and trochlear: 1 case. The mean surface area was 3.6 cm(2) (2-8) and the depth was 0.5 mm (0.4-0.8). All the patients were functionally assessed by an independent examiner using validated functional scores for these indications (KOOS, subjective IKDC). Student’s T tests were used. RESULTS: At a mean follow-up of 4 years (minimum 2 years) all but 2 patients had significantly improved (In preop. IKDC: 44±14 and KOOS: 56±17). In these 2 cases, the postoperative scores remained unchanged over the years: one patient had had several surgeries before the graft and a 51-year-old female patient had an extensive lesion of 6.9 cm(2). The mean IKDC and KOOS scores were 73±18 and 78±15 and then 77±16 and 81±14 respectively, at 1 and 4 years (p> 0.05 for IKDC and KOOS). Regrettably there were 2 complications: 1 arthrolysis 1 year after surgery and 1 algodystrophy. CONCLUSION: Few techniques are available in France for extensive symptomatic osteochondral lesions. AMIC® is a reliable, one-step, reproducible, inexpensive technique for loss of substance due to OCD with stable results as of 1 year after surgery. |
format | Online Article Text |
id | pubmed-7917857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-79178572021-03-11 The stability of outcomes of cancellous autografts with acellular membrane for extended osteochondritis of the knee. Outcomes for 22 AMIC® grafts at an average follow-up of 4 years Pauvert, Adrien Chainard, Caroline Vincelot Buisson, Xavier Robert, Henri Orthop J Sports Med Article OBJECTIVES: Loss of osteochondral substances resulting from osteochondritis dissecans (OCD) of the knee are arthrogenic in the long term. When they exceed 2 cm(2), the Autologous Matrix Induced Chondrogenesis (AMIC®) technique is one of the methods used in France. The objective of this study was to evaluate the medium-term results of the AMIC® technique. METHODS: This was a consecutive, prospective, single-center, single-operator series of 22 patients (13 men, 9 women, mean age 28 years (15-51)) treated by AMIC® (spongy bone graft + sutured collagen membrane) between September 2011 and November 2016. Previous surgery had been performed on 17 patients. According to the ICRS classification, the lesion was stage IV in 21 cases and stage III in 1 case. The sites were: condylar: 19 cases, patellar: 2 cases and trochlear: 1 case. The mean surface area was 3.6 cm(2) (2-8) and the depth was 0.5 mm (0.4-0.8). All the patients were functionally assessed by an independent examiner using validated functional scores for these indications (KOOS, subjective IKDC). Student’s T tests were used. RESULTS: At a mean follow-up of 4 years (minimum 2 years) all but 2 patients had significantly improved (In preop. IKDC: 44±14 and KOOS: 56±17). In these 2 cases, the postoperative scores remained unchanged over the years: one patient had had several surgeries before the graft and a 51-year-old female patient had an extensive lesion of 6.9 cm(2). The mean IKDC and KOOS scores were 73±18 and 78±15 and then 77±16 and 81±14 respectively, at 1 and 4 years (p> 0.05 for IKDC and KOOS). Regrettably there were 2 complications: 1 arthrolysis 1 year after surgery and 1 algodystrophy. CONCLUSION: Few techniques are available in France for extensive symptomatic osteochondral lesions. AMIC® is a reliable, one-step, reproducible, inexpensive technique for loss of substance due to OCD with stable results as of 1 year after surgery. SAGE Publications 2021-02-26 /pmc/articles/PMC7917857/ http://dx.doi.org/10.1177/2325967121S00020 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/ This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are credited. You may not alter, transform, or build upon this article without the permission of the Author(s). For article reuse guidelines, please visit SAGE’s website at http://www.sagepub.com/journals-permissions. |
spellingShingle | Article Pauvert, Adrien Chainard, Caroline Vincelot Buisson, Xavier Robert, Henri The stability of outcomes of cancellous autografts with acellular membrane for extended osteochondritis of the knee. Outcomes for 22 AMIC® grafts at an average follow-up of 4 years |
title | The stability of outcomes of cancellous autografts with acellular membrane
for extended osteochondritis of the knee. Outcomes for 22 AMIC® grafts at an average
follow-up of 4 years |
title_full | The stability of outcomes of cancellous autografts with acellular membrane
for extended osteochondritis of the knee. Outcomes for 22 AMIC® grafts at an average
follow-up of 4 years |
title_fullStr | The stability of outcomes of cancellous autografts with acellular membrane
for extended osteochondritis of the knee. Outcomes for 22 AMIC® grafts at an average
follow-up of 4 years |
title_full_unstemmed | The stability of outcomes of cancellous autografts with acellular membrane
for extended osteochondritis of the knee. Outcomes for 22 AMIC® grafts at an average
follow-up of 4 years |
title_short | The stability of outcomes of cancellous autografts with acellular membrane
for extended osteochondritis of the knee. Outcomes for 22 AMIC® grafts at an average
follow-up of 4 years |
title_sort | stability of outcomes of cancellous autografts with acellular membrane
for extended osteochondritis of the knee. outcomes for 22 amic® grafts at an average
follow-up of 4 years |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917857/ http://dx.doi.org/10.1177/2325967121S00020 |
work_keys_str_mv | AT pauvertadrien thestabilityofoutcomesofcancellousautograftswithacellularmembraneforextendedosteochondritisofthekneeoutcomesfor22amicgraftsatanaveragefollowupof4years AT chainardcarolinevincelot thestabilityofoutcomesofcancellousautograftswithacellularmembraneforextendedosteochondritisofthekneeoutcomesfor22amicgraftsatanaveragefollowupof4years AT buissonxavier thestabilityofoutcomesofcancellousautograftswithacellularmembraneforextendedosteochondritisofthekneeoutcomesfor22amicgraftsatanaveragefollowupof4years AT roberthenri thestabilityofoutcomesofcancellousautograftswithacellularmembraneforextendedosteochondritisofthekneeoutcomesfor22amicgraftsatanaveragefollowupof4years AT pauvertadrien stabilityofoutcomesofcancellousautograftswithacellularmembraneforextendedosteochondritisofthekneeoutcomesfor22amicgraftsatanaveragefollowupof4years AT chainardcarolinevincelot stabilityofoutcomesofcancellousautograftswithacellularmembraneforextendedosteochondritisofthekneeoutcomesfor22amicgraftsatanaveragefollowupof4years AT buissonxavier stabilityofoutcomesofcancellousautograftswithacellularmembraneforextendedosteochondritisofthekneeoutcomesfor22amicgraftsatanaveragefollowupof4years AT roberthenri stabilityofoutcomesofcancellousautograftswithacellularmembraneforextendedosteochondritisofthekneeoutcomesfor22amicgraftsatanaveragefollowupof4years |